COVID-۱۹: the emerging concern of Candida auris infections

  • سال انتشار: 1402
  • محل انتشار: پنجمین کنگره پژوهشی دانشجویان دانشگاه علوم پزشکی هرمزگان
  • کد COI اختصاصی: HUMS05_206
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 24
دانلود فایل این مقاله

نویسندگان

Arman barzehkar

Student Research Committee, Bandar Lengeh Faculty of Nursing, Hormozgan University of Medical Sciences, BandarAbbas, Iran

Alireza Jamali

Student Research Committee, Bandar Lengeh Faculty of Nursing, Hormozgan University of Medical Sciences, BandarAbbas, Iran

Mahdi Beirami Bastam

Student Research Committee, Bandar Lengeh Faculty of Nursing, Hormozgan University of Medical Sciences, BandarAbbas, Iran

mohammad Javad Amiri

Student Research Committee, Bandar Lengeh Faculty of Nursing, Hormozgan University of Medical Sciences, BandarAbbas, Iran

mohammad moghaddam

Student Research Committee, Bandar Lengeh Faculty of Nursing, Hormozgan University of Medical Sciences, BandarAbbas, Iran

Mehdi Shahmoradi

Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, BandarAbbas, Iran

چکیده

Introduction: Since its initial appearance in December ۲۰۱۹, the rapid spread of SARS-CoV-۲ has made it aworldwide issue of great concern. The significant rise in the number of patients requiring hospitalization hascreated a potential breeding ground for transmitting healthcare-associated infections. Candida auris is anemerging multidrug-resistant pathogen with improved transmission dynamics and resistance traits. During theworldwide spread of COVID-۱۹, we must consider the alarming increase in C. auris infections.Methods: Three databases namely PubMed, Scopus and Web of Science, as well as the Google Scholar searchengine, were searched from January ۱, ۲۰۱۹ up to September ۱۲, ۲۰۲۳ to identify relevant articles. Studieswritten in English, with data of COVID-۱۹- associated C. auris infections were of interest and eligible.Results: By a literature review, ۳۰ studies were found, of which data of COVID-۱۹-associated C. aurisinfections were extractable in ۱۴ studies (۷۵ cases). COVID-۱۹-associated C. auris infection was more commonin males (۵۱/۷۰, ۷۲.۸۶%) than females (۱۹/۷۰, ۲۷.۱۴%). Antibiotic use (۶۳/۶۸, ۹۲.۶۵%) was the most commonrisk factor, followed by steroid therapy (۴۸/۶۸, ۷۰.۵۹%), mechanical ventilation (۴۸/۶۸, ۷۰.۵۹%), the use ofurinary catheters (۳۵/۶۸, ۵۱.۴۷%), central venous catheter (۲۵/۶۸, ۳۶.۷۶%), peripherally inserted central lines(۱۲/۶۸, ۱۷.۶۵%), and vasopressor drugs (۱۲/۶۸, ۱۷.۶۵%). Regarding the comorbidities, hypertension (۳۳/۶۹,۴۷.۸۲%), diabetes mellitus (۲۵/۶۹, ۳۶.۲۳%), acute respiratory distress syndrome (۱۳/۶۹, ۱۸.۸۴%), and obesity(۱۳/۶۹, ۱۸.۸۴%) were recorded for the patients in descending order of prevalence.Conclusion: COVID-۱۹ patients are at an elevated risk of contracting C. auris infections due to longer hospitalstays and increased need for intensive care. This fungus can circulate within healthcare settings, leading tooutbreaks. Additionally, the unique conditions in COVID-۱۹ patients promote the selection of drug-resistantorganisms, putting them at risk for coinfections with multidrug-resistant C. auris. Therefore, it is crucial toprioritize prompt diagnosis and targeted treatment of these infections in COVID-۱۹ patients

کلیدواژه ها

Candida auris, Co-infection, COVID-۱۹, SARS-CoV-۲

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.